Green porphyrins as immunomodulators
AssigneeQuadra Logic Technologies, Inc.
InventorsAgnes How-Ching Chan, David William Carey Hunt, Julia Levy, Modestus Onuora Kay Obochi, Anna Richter, Guillermo O. Simkin
Life of this patent
Estimating the term…
Abstract
Green porphyrins act as antigen-specific immunomodulators in the active phase of an immune response to a particular antigen, as well as to interfere with intercellular communication. These effects occur in the absence of radiation absorbed by the green porphyrin.
Claims14
A method to modulate an antigen-specific immune response which method comprises administering to a subject in need of such modulation, an amount of green porphyrin effective to modulate said immune response to the antigen in the absence of radiation absorbed by the green porphyrin, said administering being performed during the ongoing antigen-specific immune response to said antigen.
A method to inhibit thrombosis which method comprises administering to a subject an amount of green porphyrin that is effective to inhibit formation of a clot in the absense of radiation absorbed by the green porphyrin.
Dependencies are inferred from the claim text.